- Advertise
- Contact Editorial
- Editorial Submission Guidelines
- Contact MJH Life Sciences
- Do Not Sell My Personal Information
- Privacy Policy
- Terms and Conditions
© 2023 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.
Pharmaceutical Executive-10-01-2019
Pharmaceutical Executive
Tech Tour for the C-Suite: Pharma’s Digital Future
November 04, 2019
Features
39
10
Amid new findings on today’s C-suite mood and approach to digital transformation, experts-in a panel discussion and wider examinations by Pharm Exec editors-explore the intersection of data and technology and the areas that must evolve to meet the digital health demands of tomorrow.
It Starts with a Scribble
October 10, 2019
From the Editor
39
10
Our quest to make sense of a complex future data ecosystem in pharma.
Olivier Laureau, Servier: Free to Grow, Innovate
October 09, 2019
Features
39
10
French independent pharma Servier Group, led by president Olivier Laureau, is uniquely positioned to capitalize on new opportunities for expansion and stay true to its R&D and patient-focused mission.
Corey McCann: A PDT Pioneer
October 09, 2019
Features
39
10
Corey McCann, president and CEO of Pear Therapeutics, discusses how the prescription digital therapeutics space has evolved in a decade from disruptive concept to an exciting, growing market.
Data Shape-Up: Striving to Standardize
October 09, 2019
Features
39
10
With a growing abundance of clinical and health information now available and achievable, the need for industry to apply common structures and rules to interpret and act on this data is critical.
Policy Sync-Up: The Drug Importation Conundrum
October 08, 2019
Columns
39
10
Coexisting with the DSCSA may hinder new legislative efforts.
Validating Value Data: AI and Outcomes
October 08, 2019
Features
39
10
Realizing the full potential of enabling technologies such as AI and machine learning in measuring treatment value and outcomes.
Underlying Platform: Data Unleashed
October 08, 2019
Features
39
10
In keeping pace with the digital transformation, pharma companies are doing pretty well with data and infrastructure, but a fundamental reshaping of operating models remains the biggest hurdle to moving forward.
Surfing the Wave: The Patient-Data Puzzle
October 08, 2019
Features
39
10
While commercial websites can employ analytics to gain better snapshots of their visitors, pharma faces far greater challenges in using technology as a way to track and understand its consumers.
Where Does Europe’s Drug Industry Go from Here?
October 07, 2019
Columns
39
10
Change in season ushers in a pivotal period for pharma in shaping the direction of EU healthcare.
Data Integrity Scandal Prompts FDA Probe
October 07, 2019
Columns
39
10
Lapse spotlights wider actions to ensure data accuracy.
How to Harness, Leverage Key Online Influencers
October 01, 2019
Columns
39
10
The importance of KOIs in tapping into today’s market mindset.
Pharma Automation: Avoiding the Dangers
October 01, 2019
Columns
39
10
The key steps to evading automation-fueled data crises.
Pharmaceutical Executive, October 2019 Issue (PDF)
October 01, 2019
Issue PDF
39
10
Click the title above to open the Pharmaceutical Executive October 2019 issue in an interactive PDF format.
Country Report: Thailand
October 01, 2019
Special Sponsored Section
39
10
After two decades of building a robust healthcare ecosystem, Thailand is seeking to move to the next level-Thailand 4.0-a potential stepping stone in its strategy to initiate a transformative era with a greater embrace of R&D.